BioSpace News Archive

Exact Sciences Corp. announced performance data for a second-generation Cologuard test showing overall sensitivity of 95.2% for colorectal cancer at specificity of 92.4% for negative samples confirmed by colonoscopy.

Positive results from the TOPAZ-1 Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care chemotherapy, demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) and progression-free survival (PFS) versus chemotherapy alone as a 1st-line treatment for patients with advanced biliary tract cancer (BTC).

HUTCHMED Limited announces that updated analysis of the ongoing international Phase I/Ib trial of fruquintinib will be presented at the upcoming 2022 ASCO Gastrointestinal Cancers Symposium, taking place on January 20-22, 2022.

BrainChip Holdings Ltd announced that the US Patents and Trademarks Office has issued BrainChip US Patent 11,227,210 “Event-based Classification of Features in a Reconfigurable and Temporally Coded Convolutional Spiking Neural Network.”

The demand within the global ventilator test systems market has been expanding on account of the need to install fool-proof medical equipment across hospitals and healthcare centers.

The global veterinary drugs market is estimated to register growth at a CAGR of 5.1% during the forecast period of 2016 to 2024.

Positive reimbursement strategies by governments and key players for medical gadgets and instruments are anticipated to help the development of the market over the forthcoming years.

Medical aesthetic devices are those medical devices that are utilized for the purposes of cosmetic procedures, which comprise skin tightening, aesthetic implants, anti-aging, excess fat removal, unwanted hair removal, unwanted hair removal, and plastic surgery.

Rising consumption of illegal drugs is resulting into increase in the requirement for drug abuse tests.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global wireless portable medical devices market is anticipated to grow at 11% CAGR between 2021 and 2031 to reach valuation of US$ 33 Bn by 2031.The market was valued at US$ 15 Bn in 2020.